This webinar will give you a better understanding of how the end of one-size-fits all medicine, and current oncology drug developments in diagnosis and biomarkers positively impact clinical trials. It will also address key oncology drug development barriers...
Cancer drug development is the most complex challenge faced by the drug industry today, with clinical trials being the most technically difficult, time consuming and expensive aspect of the process. Recruiting patients, monitoring sites and...
On average over half the cost of developing a new cancer drug is associated with work outsourced to contract research organisations (CRO), according to analysis by Cutting Edge Information. This finding, coupled with the pharmaceutical industry’s ever...
Recruiting patients is often, if not always, the most expensive and time consuming part of a clinical trial. For oncology drug development the problem is particularly pronouncedThis presentation will focus on new techniques to improve access to the right...
The way drug companies work with CROs is evolving, with the emphasis shifting from the client-service provider model to a more strategic, long-term relationship focused approach.This presentation will discuss the role strategic partnerships can play in...
Recruiting patients is often, if not always, the most expensive and time consuming part of a clinical trial. For oncology drug development the problem is particularly pronounced.This presentation will focus on new techniques to improve access to the right...
“Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of a high number of unmet needs for improved treatments in different types of cancer. In 2009, around 40,000 Phase I, II and III trials were listed...
Learn how to maximize registrations and retain viewer attention for your webinars. Get expert advice and tips from the online marketing solutions team at William Reed Business Media. After you attend this free web seminar, you will know how to create...
